Key Highlights

  • True North Copper entered voluntary administration in October 2024, was recapitalised through a AUD 50.3 million underwritten placement at AUD 0.005 and a one-for-100 share consolidation, and was reinstated to ASX quotation in January 2025; it currently trades under its original name and TNC ticker.
  • The company is pre-revenue: mining at Wallace North ceased in October 2024, the Great Australia processing hub is in care and maintenance, and the February 2024 Mining Restart Study is no longer relied upon.
  • A Cloncurry pre-feasibility study and maiden ore reserve are guided to the December 2026 quarter, the same window in which AUD 7.5 million of deferred Mt Oxide consideration falls due.
  • Recent Aquila assays support the exploration case, but the company remains pre-revenue and its processing hub is in care and maintenance.

Eighteen months after administrators, a deed of company arrangement and a one-for-100 consolidation reset its register, True North Copper is again a drill-driven story. A softer session for the Queensland copper hopeful lands as fresh Mt Oxide assays and a Cloncurry study deadline converge.

Why the stock is in focus

True North Copper is not a producer having a quiet day. The entity trading under the TNC code is the product of a formal insolvency: KordaMentha administrators were appointed on 21 October 2024, the shares were suspended, and a deed of company arrangement followed in November.

What followed rebuilt the register. A fully underwritten AUD 50.3 million placement issued 10.06 billion shares at AUD 0.005, a share purchase plan at the same price ran in December 2024, and every 100 shares were then consolidated into one. The company was reinstated in January 2025, suspended briefly again that March over its half-year accounts, and has since traded under an unchanged name and ticker.

The share-price movement

A client-supplied screener reading recorded ASX:TNC at around AUD 0.39, down roughly 3.9 per cent in a single session. True North Copper did not appear in the TradingView screener of Australian decliners supplied for this series, so the figure is an uncorroborated, point-in-time reading rather than a verified closing price, and Kalkine has not been able to independently confirm it against official ASX market data.

ASX market-data feeds on 28 July 2026 showed the stock near AUD 0.39 after a fall of similar order. On about 155.4 million shares that implies a market value near AUD 60 million, against a twelve-month range of about AUD 0.22 to AUD 0.76.

No single confirmed company-specific catalyst was identified for the share-price movement. Price-sensitive drilling results landed the same morning, but management framed them positively and any link is inference.

Latest announcement or development

On 28 July 2026 True North reported assays from three diamond holes at the Aquila copper-cobalt-silver discovery at Mt Oxide. One returned 35 metres at 0.82 per cent copper, 0.04 per cent cobalt and 3.4 grams per tonne silver from 32 metres, including four metres at 4.08 per cent copper. Management described a broad stockwork system over 1.8 kilometres of strike.

Eight days earlier the company signed a conditional agreement to sell the non-core Bundarra copper-silver project to Tec Minerals Pty Ltd for AUD 500,000 in staged cash and AUD 1.0 million in shares of a listed Tec Minerals vehicle, keeping a 1 per cent net smelter return royalty. That sale depends on Tec Minerals completing a listing and has not completed.

Recent financial and operational performance

True North is pre-revenue. Mining at Wallace North began in July 2024 and ceased that October when administrators arrived, and the Great Australia processing hub sits in care and maintenance. The December 2024 prospectus said the company no longer relied on the February 2024 Mining Restart Study mine plan, because its material assumptions no longer applied.

Activity through 2026 has been drilling and study work: development holes at Cloncurry from February, Wallace North from April and a Mt Oxide campaign from late April, supported by Queensland grants of AUD 400,000 and AUD 250,000. Half-year accounts and an Appendix 5B were lodged in March and April, but those ASX-hosted PDFs sit behind a terms-of-access page and could not be read.

Business model and principal assets

The strategy is a hub-and-spoke development play in the Mt Isa Inlier across two wholly owned project areas. Mt Oxide, roughly 100 kilometres north of the Mt Isa smelter, hosts the Vero deposit at 15.03 million tonnes grading 1.46 per cent copper and 10.59 grams per tonne silver, for 220,000 tonnes of contained copper and 5.13 million ounces of silver, plus cobalt.

Cloncurry carries 16.73 million tonnes at 0.75 per cent copper for about 126,000 tonnes of copper and 91,000 ounces of gold across Great Australia, Taipan, Wallace North and Mongoose, roughly 90 per cent on granted mining leases, alongside an idle refurbished solvent extraction plant, flotation circuit and heap leach pads. In June 2026 the company completed the purchase of Renegade Exploration's Carpentaria Joint Venture and Mongoose interests for AUD 2.88 million.

Growth opportunities

Two workstreams dominate the year ahead. At Cloncurry a pre-feasibility study is under way, with completion and a maiden ore reserve guided to the December 2026 quarter and the possibility of mining recommencing in 2027 raised by the company. No development decision has been taken.

At Mt Oxide the aim is a maiden Aquila resource and testing of the Apollo, Acanthis and Rhea targets. Management has described an ambition of growing Mt Oxide toward a 50 to 60 million tonne copper resource, using 29Metals' nearby Capricorn deposit as an analogue. That is an aspiration, not a forecast.

Balance sheet, funding and cash flow

On July 2026 company disclosure, True North held AUD 12.3 million of cash at 31 March 2026 alongside AUD 15.3 million of restricted cash, no interest-bearing debt, and AUD 7.5 million of deferred Mt Oxide consideration payable in December 2026. That obligation was cut from AUD 15 million during the restructure and falls due in the same quarter as the Cloncurry study.

Funding since relisting has come from equity, including a AUD 12.5 million placement announced in December 2025. The register is concentrated: Tembo Capital about 24.5 per cent, Regal Funds Management 6.5 per cent, Glencore Australia 6.3 per cent and Nebari 5.3 per cent.

Principal risks

The clearest risk is a repeat of the 2024 failure mode, which the company attributed to being undercapitalised, to cost increases during the Cloncurry ramp-up, to low copper grades in leach solution and to downtime at the solvent extraction plant.

Beyond that, the study may not support an economic reserve; much of the resource base is inferred and may never convert; the December 2026 payment must come from cash or new equity; restricted cash is not freely available; and the Bundarra sale hinges on a third party listing. Copper prices and cost inflation cut both ways, though all assets sit in Queensland.

Valuation and investor expectations

Conventional multiples do not apply. With no revenue, earnings or dividend, price-to-earnings and forward price-to-earnings, EV/EBITDA, price-to-sales and free-cash-flow yield are all meaningless here.

The July 2026 presentation put market capitalisation at about AUD 62.2 million and enterprise value near AUD 57.7 million at a AUD 0.40 share price, close to the level implied by the reading under discussion. Against roughly 346,000 tonnes of contained copper, that is a modest figure per in-ground tonne, broadly what markets pay for undeveloped, partly inferred resources with no reserve and a recent insolvency. No reliable analyst forecasts were located, and multiples change continuously.

Outlook

The next two quarters carry the load. Further Aquila, Apollo and Acanthis assays are due through the rest of 2026, the Cloncurry study and any maiden reserve are guided to the December quarter, and the AUD 7.5 million Mt Oxide payment falls in the same window.

For a company rebuilt out of administration barely eighteen months ago, the question is whether drilling and study work convert into a funded development plan before cash tightens again. A single-session decline of this size says little on its own; the December quarter should say much more.